160 related articles for article (PubMed ID: 30657575)
1. Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients.
Cimen AO; Emet S; Elitok A
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):338-342. PubMed ID: 30657575
[TBL] [Abstract][Full Text] [Related]
2. Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery.
Bouglé A; Allain PA; Favard S; Ait Hamou N; Carillion A; Leprince P; Granger B; Amour J
Anaesth Crit Care Pain Med; 2018 Dec; 37(6):565-570. PubMed ID: 29476941
[TBL] [Abstract][Full Text] [Related]
3. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T
Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956
[TBL] [Abstract][Full Text] [Related]
4. Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.
Madhivathanan PR; Fletcher N; Gaze D; Thomson R; Chandrasekaran V; Al-Subaie N; Valencia O; Sharma V
Cytokine; 2016 Jul; 83():8-12. PubMed ID: 26999704
[TBL] [Abstract][Full Text] [Related]
5. Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina.
Çimen T; Efe TH; Akyel A; Sunman H; Algül E; Şahan HF; Erden G; Özdemir Ş; Alay EF; Doğan M; Yeter E
Angiology; 2016 Oct; 67(9):846-53. PubMed ID: 26744512
[TBL] [Abstract][Full Text] [Related]
6. Serum Endothelial Cell-Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance.
Qiu CR; Fu Q; Sui J; Zhang Q; Wei P; Wu Y; Zhu K; Lu Y; Zong B
Angiology; 2017 Apr; 68(4):354-359. PubMed ID: 27225701
[TBL] [Abstract][Full Text] [Related]
7. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
[TBL] [Abstract][Full Text] [Related]
8. Endothelium biomarkers endocan and thrombomodulin levels in isolated coronary artery ectasia.
Baysal SS; Koç Ş; Güneş A; Altiparmak IH
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4677-4682. PubMed ID: 30058709
[TBL] [Abstract][Full Text] [Related]
9. Elevated endocan concentration is associated with coronary slow flow.
Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM
Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.
Poinsot PA; Barrucand B; Ecarnot F; Lassalle P; Besch G; Chocron S; Perrotti A
Cytokine; 2018 Oct; 110():328-332. PubMed ID: 29627158
[TBL] [Abstract][Full Text] [Related]
11. Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.
Emet S; Elitok A; Onur I; Kocaaga M; Bilge AK; Oflaz H; Umman B; Oncul A; Bugra Z; Adalet K; Mercanoglu F
J Thromb Thrombolysis; 2017 Jan; 43(1):60-67. PubMed ID: 27638814
[TBL] [Abstract][Full Text] [Related]
12. Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia.
Turan T; Akyuz AR; Aykan AC; Kul S; Cirakoglu OF; Aslan AO; Gul I; Uçar U; Demir S; Celik S
Angiology; 2016 Nov; 67(10):932-936. PubMed ID: 26980772
[TBL] [Abstract][Full Text] [Related]
13. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon].
Sığırcı S; Sarıkaya R; Keskin K; Yıldız SS; Pilten Güzel S; Çetinkal G; Önur İ; Kılıçkesmez KO
Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439
[TBL] [Abstract][Full Text] [Related]
14. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
15. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
16. Endocan: A Novel Predictor of Endothelial Dysfunction in Silent Brain Infarction.
Erdal Y; Yavuz N; Oguz O; Mahmutoglu AS; Emre U
Angiology; 2021 Oct; 72(9):850-854. PubMed ID: 33902352
[TBL] [Abstract][Full Text] [Related]
17. Endocan: A novel inflammatory indicator in cardiovascular disease?
Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
[TBL] [Abstract][Full Text] [Related]
18. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
[TBL] [Abstract][Full Text] [Related]
19. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension.
Wang XS; Yang W; Luo T; Wang JM; Jing YY
Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Serum Endothelial Cell-Specific Molecule 1 (Endocan) Level in Type 2 Diabetes Mellitus With Acute ST-Segment Elevation Myocardial Infarction and its Correlation: A Pilot Study.
Qiu CR; Fu Q; Sui J; Zhang Q; Wei P; Wu Y; Zhu K; Lu Y; Wan P
Angiology; 2017 Jan; 68(1):74-78. PubMed ID: 26927690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
